Menveo 1 vial-a-c-y-w-135-DIP 0.5ML

Ended Awarded Last action

Contract number
SPE2DR26FJQ3J
Awardee
Awarding agency
Obligated
$29,975

Award facts

Contract value 100% obligated
$29,975.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
424210 Drugs and Druggists' Sundries Merchant Wholesalers
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Conshohocken, PA 19428, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Logistics Agency issued a $29,975 delivery order to AmerisourceBergen Drug Corp on March 4, 2026, for Menveo 1 vial pharmaceutical product (0.5 mL, diptheria-pertussis-tetanus combination vaccine). The order is placed under the parent company Cencora, Inc.'s DLA Troop Support Medical indefinite delivery contract (SPE2DX), valued at up to $999,999,999 through December 2026.

Place of performance is Conshohocken, Pennsylvania. The order has a firm fixed-price structure with an ultimate completion date of March 5, 2026. No set-aside was used in this award.

Quick answers

Who was awarded contract SPE2DR26FJQ3J?

SPE2DR26FJQ3J was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on March 4, 2026.

How much is contract SPE2DR26FJQ3J worth?

The government has obligated $29,975 on SPE2DR26FJQ3J.

Is contract SPE2DR26FJQ3J an order under another contract?

Yes. SPE2DR26FJQ3J is a delivery order under SPE2DR25D1106, an indefinite delivery contract.

Was contract SPE2DR26FJQ3J competed?

The extent of competition for SPE2DR26FJQ3J was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award